HYPROMELLOSE

The recommended dosage for adults, children and elderly is one or two drops topically instilled into the eye three times daily as needed, or as directed by a physician.

Method of administration:

For ocular use only.

The following adverse reactions have been reported following administration of Hypromellose.

Frequency cannot be estimated from the available data:

Eye disorder: • transient mild stinging or vision blurred, • eye pain, • foreign body sensation in eyes, • eye irritation, • ocular hyperaemia. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important.

It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

May cause transient mild stinging or temporary blurred vision. 8). In order to preserve the sterility, the dropper should not be allowed to touch any part of the eye or any other surface. (Label warning: Do not touch any part of the eye with the dropper).

1mg/ml benzalkonium chloride as preservative which may be deposited in soft contact lenses. Hence, Hypromellose should not be used while wearing these lenses. The lenses should be removed before instillation of the drops and not reinserted earlier than 15 minutes after use.

Benzalkonium chloride has been reported to cause eye irritation, symptoms of dry eyes and may affect the tear film and corneal surface. Should be used with caution in dry eye patients and in patients where the cornea may be compromised.

Patients should be monitored in case of prolonged use.

1.